CN104706721A - Antibacterial and inflammation-eliminating traditional Chinese medicine composition - Google Patents

Antibacterial and inflammation-eliminating traditional Chinese medicine composition Download PDF

Info

Publication number
CN104706721A
CN104706721A CN201310683678.XA CN201310683678A CN104706721A CN 104706721 A CN104706721 A CN 104706721A CN 201310683678 A CN201310683678 A CN 201310683678A CN 104706721 A CN104706721 A CN 104706721A
Authority
CN
China
Prior art keywords
parts
chinese medicine
inflammation
traditional chinese
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310683678.XA
Other languages
Chinese (zh)
Inventor
曹斌
肖庆涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yada Pharmaceuticals Co Ltd Of Wenzhou Economic & Technical Development Zone
Original Assignee
Yada Pharmaceuticals Co Ltd Of Wenzhou Economic & Technical Development Zone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yada Pharmaceuticals Co Ltd Of Wenzhou Economic & Technical Development Zone filed Critical Yada Pharmaceuticals Co Ltd Of Wenzhou Economic & Technical Development Zone
Priority to CN201310683678.XA priority Critical patent/CN104706721A/en
Publication of CN104706721A publication Critical patent/CN104706721A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses an antibacterial and inflammation-eliminating traditional Chinese medicine composition, and belongs to the field of traditional Chinese medicines. The antibacterial and inflammation-eliminating traditional Chinese medicine composition comprises the following traditional Chinese medicine raw materials by weight: 5-12 parts of coptis chinensis, 3-10 parts of strychnos nux-vomica, 3-8 parts of cnidium monnieri (l.) cuss, 5-10 parts of argy wormwood leaf, 2-10 parts of atractylodes lancea, and 2-15 parts of radix sophorae flavescentis, and is the granules, tablets, capsules or tinctures. The antibacterial and inflammation-eliminating traditional Chinese medicine composition of the present invention has the following characteristics that: the compatibility is scientific, the significant inflammation-eliminating and antibacterial effect is provided, the traditional Chinese medicines are safe and do not have side effects, various herbs in the composition are easy to obtain and are inexpensive, and the method is suitable for mass production.

Description

The Chinese medicine composition of anti-inflammation
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to a kind of Chinese medicine composition of anti-inflammation.
Background technology
Inflammation is very common and important basic pathology process, and the trauma infection contamination of body surface and most of commonly encountered diseases of each organ and frequently-occurring disease (as furuncle, carbuncle, pneumonia, hepatitis, nephritis etc.) all belong to diseases associated with inflammation.The defensive reaction of biological tissue to damage factor with vascular system is called inflammation.
Vascular reaction is the key link of inflammatory process.Inflammation is exactly people's said " inflammation " at ordinary times, be body for a kind of defense reaction stimulated, show as red, swollen, hot, bitterly and dysfunction.Inflammation can be infect the infective inflammation caused, and may not be owing to infecting the non-infectious inflammation caused.Under normal circumstances, inflammation is useful, is the automatic defense reaction of human body, but sometimes, inflammation is also harmful, such as, to the attack of human body autologous tissue, the inflammation occurring in hyaline tissue etc.
In inflammatory process, damage factor directly or indirectly causes the destruction of tissue and cell on the one hand, and another aspect is by inflammatory congestion and ooze out reaction, to dilute, to kill and wound and to surround damage factor.Make impaired tissue be repaired and heal by the regeneration of essence and Interstitial cell simultaneously.Therefore can say that inflammation is the RUP of damage and antibody Monoclonal.
During western medicine inflammation, usually use antibiotic, antibiotic side effect is large, and has grown easy generation dependency and Drug resistance service time.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition of anti-inflammation of instant effect.
In order to realize foregoing invention object, the technical solution used in the present invention is:
The Chinese medicine composition for the treatment of rhinitis of the present invention, it is made up of the raw material of Chinese medicine of following weight: Fructus Xanthii 5-15 part, Radix Cynanchi Paniculati 2-10 part, Herba Menthae 1-6 part, Radix Saposhnikoviae 5-15 part, Herba Asari 4-10 part, Rhizoma Chuanxiong 4-15 part, Radix Astragali 5-25 part, Rhizoma Atractylodis Macrocephalae 5-20 part and Poria 4-15 part.
The Chinese medicine composition of described a kind of anti-inflammation, it is made up of the raw material of Chinese medicine of following weight: Rhizoma Coptidis 5-12 part, Semen Strychni 3-10 part, Fructus Cnidii 3-8 part, Folium Artemisiae Argyi 5-10 part, Rhizoma Atractylodis 2-10 part and Radix Sophorae Flavescentis 2-15 part.
The Chinese medicine composition of described anti-inflammation, it is made up of the raw material of Chinese medicine of following weight: Rhizoma Coptidis 10 parts, Semen Strychni 8 parts, Fructus Cnidii 6 parts, Folium Artemisiae Argyi 8 parts, Rhizoma Atractylodis 8 parts and Radix Sophorae Flavescentis 10 parts.
The Chinese medicine composition of described anti-inflammation, described anti-inflammation Chinese medicine composition is granule, tablet, capsule or tincture.
Rhizoma Coptidis: have heat clearing and damp drying, effect of eliminating fire and detoxication.
Semen Strychni: excited stomach invigorating, detumescence poison, removing heat from blood.Cure mainly numb limbs and tense tendons, paralysis, inappetence, mass in the abdomen, carbuncle pyogenic infections from tumour or sore, laryngopharynx swelling and pain.
Fructus Cnidii: warm in nature, acrid in the mouth, hardship.Function cures mainly: warming the kidney to invigorate YANG, and dampness is dispeled the wind, parasite killing.For sexual impotence, cold womb, cold-damp leukorrhagia, arthralgia chiefly caused by damp pathogen lumbago; External treatment vulval eczema, married woman's pudendal pruritus, trichomonal vaginitis.
Folium Artemisiae Argyi: energy dispelling cold and removing dampness, warming the meridian for stopping bleeding.
Rhizoma Atractylodis: have stronger antiulcer action.
Radix Sophorae Flavescentis: heat clearing and damp drying, parasite killing, diuresis.For hematodiarrhoea, have blood in stool, jaundice urine retention, leucorrhea with red and white discharge, swelling of the vulva pudendal pruritus, eczema, eczema, skin pruritus, scabies leprosy; External treatment trichomonal vaginitis.
Compared with prior art, the invention has the advantages that: Chinese medicine composition compatibility science of the present invention, antiphlogistic antibacterial Be very effective, and Chinese medicine safety, have no side effect, the various medical materials in compositions, is easy to obtain, cheap, is suitable for batch production.
Detailed description of the invention
Embodiment 1
The Chinese medicine composition for the treatment of rhinitis, it is made up of the raw material of Chinese medicine of following weight:
Fructus Xanthii 5 parts, Radix Cynanchi Paniculati 10 parts, Herba Menthae 6 parts, Radix Saposhnikoviae 15 parts, Herba Asari 10 parts, Rhizoma Chuanxiong 15 parts, the Radix Astragali 25 parts, the Rhizoma Atractylodis Macrocephalae 20 parts and 15 parts, Poria.
Embodiment 2
The Chinese medicine composition for the treatment of rhinitis, it is made up of the raw material of Chinese medicine of following weight:
Fructus Xanthii 8 parts, Radix Cynanchi Paniculati 4 parts, Herba Menthae 2 parts, Radix Saposhnikoviae 6 parts, Herba Asari 5 parts, Rhizoma Chuanxiong 6 parts, the Radix Astragali 8 parts, the Rhizoma Atractylodis Macrocephalae 10 parts and 6 parts, Poria.
Embodiment 3
The Chinese medicine composition for the treatment of rhinitis, is characterized in that: it is made up of the raw material of Chinese medicine of following weight: Fructus Xanthii 10 parts, Radix Cynanchi Paniculati 6 parts, Herba Menthae 4 parts, Radix Saposhnikoviae 10 parts, Herba Asari 6 parts, Rhizoma Chuanxiong 10 parts, the Radix Astragali 15 parts, the Rhizoma Atractylodis Macrocephalae 12 parts and 10 parts, Poria.

Claims (3)

1. a Chinese medicine composition for anti-inflammation, is characterized in that: it is made up of the raw material of Chinese medicine of following weight: Rhizoma Coptidis 5-12 part, Semen Strychni 3-10 part, Fructus Cnidii 3-8 part, Folium Artemisiae Argyi 5-10 part, Rhizoma Atractylodis 2-10 part and Radix Sophorae Flavescentis 2-15 part.
2. the Chinese medicine composition of anti-inflammation according to claim 1, is characterized in that: it is made up of the raw material of Chinese medicine of following weight: Rhizoma Coptidis 10 parts, Semen Strychni 8 parts, Fructus Cnidii 6 parts, Folium Artemisiae Argyi 8 parts, Rhizoma Atractylodis 8 parts and Radix Sophorae Flavescentis 10 parts.
3. the Chinese medicine composition of anti-inflammation according to claim 1, is characterized in that: described anti-inflammation Chinese medicine composition is granule, tablet, capsule or tincture.
CN201310683678.XA 2013-12-14 2013-12-14 Antibacterial and inflammation-eliminating traditional Chinese medicine composition Pending CN104706721A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310683678.XA CN104706721A (en) 2013-12-14 2013-12-14 Antibacterial and inflammation-eliminating traditional Chinese medicine composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310683678.XA CN104706721A (en) 2013-12-14 2013-12-14 Antibacterial and inflammation-eliminating traditional Chinese medicine composition

Publications (1)

Publication Number Publication Date
CN104706721A true CN104706721A (en) 2015-06-17

Family

ID=53406766

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310683678.XA Pending CN104706721A (en) 2013-12-14 2013-12-14 Antibacterial and inflammation-eliminating traditional Chinese medicine composition

Country Status (1)

Country Link
CN (1) CN104706721A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105395930A (en) * 2015-11-30 2016-03-16 梁苡玮 Antisepsis and anti-inflammation drug for external use
CN107549469A (en) * 2017-10-30 2018-01-09 王斌 One breeding hen feed and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105395930A (en) * 2015-11-30 2016-03-16 梁苡玮 Antisepsis and anti-inflammation drug for external use
CN107549469A (en) * 2017-10-30 2018-01-09 王斌 One breeding hen feed and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101972389B (en) Chinese medicinal composition for treating dermatosis
CN102309699A (en) Traditional Chinese medicine (TCM) prescription for treating cervical cellulitis
CN104706721A (en) Antibacterial and inflammation-eliminating traditional Chinese medicine composition
CN101045091B (en) Traditional Chinese medicine decoction for treating acute toothache
CN103479980B (en) Plaster for treating acute lymphadenitis
CN103417774B (en) Traditional Chinese medicine and preparing method and application thereof
CN102366528A (en) Chinese herbal medicine for treating blepharitis
CN104189784A (en) Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation
CN107913377A (en) It is a kind of treat rheumatic disease harvest sub- wine and preparation method thereof
CN106511584A (en) Drug for treating postpartum fever
CN103127465B (en) Chinese medicament for treating mammary gland hyperplasia
CN103316252B (en) A kind of Chinese medicine for the treatment of hepatic fibrosis
CN104623112A (en) Plaster for treating snake-head furuncle
CN104248681A (en) Traditional Chinese medicine granule for treatment of rheumathritis and preparation method thereof
CN102940775B (en) Traditional Chinese medicine used for preventing and treating liver and gall diseases, and preparation method and application thereof
CN102940814B (en) Medicine for treating tubal nowhere
CN102462783A (en) Medicinal composition and preparation for treating condyloma acuminatum
CN102048963A (en) TCM prescription for treating migraine
CN105194263A (en) Traditional Chinese medicine composition for treating rheumatic skin itching and preparation method thereof
CN105106850A (en) Medicinal preparation for treating dysmenorrhea
CN105267359A (en) Externally-applied tincture medicine for treatment of scrotum eczema and preparation method of externally-applied tincture medicine for treatment of scrotum eczema
CN103536689A (en) Pudendum cleaning bacteriostat liquid and preparation process thereof
CN103989953A (en) Traditional Chinese medicinal composition for treating infantile paralysis
CN103110865A (en) Traditional Chinese medicine for treating enterobiasis
CN1840007A (en) Wine for treating sterility

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150617